Amyloidosis is an underdiagnosed, progressive group of diseases characterized by the abnormal buildup of a protein called ...

"AstraZeneca’s AL amyloidosis drug fails to impress in Phase III" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

AstraZeneca on Wednesday said that its experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of AL amyloidosis, a rare condition that causes a buildup of ...

Hereditary amyloidosis is usually caused by inherited genetic mutations that cause abnormal amyloid proteins to build up and damage different organs in the body. Here’s what you need to know ...

AstraZeneca's experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of a rare ...

Amyloidosis has “nonspecific” symptoms, meaning they can be the result of many medical conditions and problems, so identifying and diagnosing the disease is difficult. Here are the steps your ...

So, for AL amyloidosis, we can offer chemo therapy and even a bone marrow transplantation with very good outcomes with several years of survival. I have a patient with a diagnosis of AL amyloidosis ...

Amyloidosis is classified into three main forms depending on the cause of the condition. The condition is also referred to as either localized when only one site of the body is affected, or ...

Amyloidosis, a disease in which misfolded proteins form amyloid fibrils that deposit in tissues and organs including the heart, is a vexing condition with devastating consequences. Encouragingly ...

PITTSBURGH (KDKA) -- Amyloidosis is a rare condition that used to almost always be fatal, but doctors are finally making progress in treating it. "I had so many symptoms, and I really didn't think ...

Localized amyloidosis is usually less serious than the systemic form. Diagnosis is also complicated by the fact that the symptoms of amyloidosis are similar to those seen in other conditions that ...